Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients

  • Marie Jakobsen1Email author,
  • Mette Dalsgaard1,
  • Morten Hørmann1 and
  • Daniél Vega Møller2
BMC Endocrine Disorders201212:21

DOI: 10.1186/1472-6823-12-21

Received: 29 June 2012

Accepted: 20 September 2012

Published: 25 September 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
29 Jun 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Jul 2012 Author responded Author comments - Marie Jakobsen
Resubmission - Version 3
6 Jul 2012 Submitted Manuscript version 3
16 Aug 2012 Reviewed Reviewer Report - Pablo Aschner
20 Aug 2012 Reviewed Reviewer Report - Bruce Bode
19 Sep 2012 Author responded Author comments - Marie Jakobsen
Resubmission - Version 4
19 Sep 2012 Submitted Manuscript version 4
20 Sep 2012 Author responded Author comments - Marie Jakobsen
Resubmission - Version 5
20 Sep 2012 Submitted Manuscript version 5
Publishing
20 Sep 2012 Editorially accepted
25 Sep 2012 Article published 10.1186/1472-6823-12-21

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
COWI A/S
(2)
Novo Nordisk Scandinavia AB

Advertisement